Geroscience Explained: The New Science of Treating Aging as a Disease

You've probably heard that aging is inevitable, that chronic disease is just part of getting older, and that the best you can do is manage symptoms as they appear. But what if the diseases we associate with aging aren't separate conditions at all? What if they're all downstream consequences of a single, modifiable process? (NIA: geroscience at the intersection of aging biology and chronic disease) (translational geroscience: a new paradigm for 21st century medicine)

Key Takeaways

• Geroscience proposes that aging itself drives most chronic diseases, not the reverse.
• Targeting aging mechanisms may prevent multiple diseases simultaneously rather than one at a time (hallmarks of aging underlying geroscience).
• The hallmarks of aging provide a biological framework for understanding disease susceptibility.
• Drugs like rapamycin and metformin are being studied for their effects on aging pathways (Targeting Aging with Metformin (TAME) trial).
• Geroscience is shifting preventive medicine from disease-specific to aging-focused interventions.
• Clinical trials now measure biological age and healthspan, not just single disease outcomes.
• Individual variation in aging rate explains why chronological age predicts health poorly.

What Geroscience Actually Is at a Biological Level

Geroscience is the study of aging as the primary risk factor for chronic disease. Rather than treating heart disease, diabetes, cancer, and dementia as independent conditions, geroscience recognizes them as manifestations of the same underlying process: the progressive breakdown of cellular and molecular systems that maintain homeostasis. The central hypothesis is straightforward: if you slow the rate of aging, you delay the onset and severity of multiple age-related diseases at once.

This represents a fundamental shift in how we think about disease prevention. Traditional medicine targets individual pathologies after they emerge. Geroscience targets the biological mechanisms that make those pathologies more likely in the first place. The distinction matters because aging is not a passive accumulation of damage. It's an active, measurable process driven by specific cellular and molecular changes that can be modified.

At the molecular level, aging involves the progressive failure of systems that repair DNA, clear damaged proteins, maintain mitochondrial function, and regulate inflammation. These failures don't happen in isolation. They compound one another, creating a cascade of dysfunction that increases vulnerability to disease. Geroscience seeks to identify the points in this cascade where intervention is most effective, and to develop therapies that target those points directly.

How Geroscience Connects to the Hallmarks of Aging

The hallmarks of aging, first described by López-Otín and colleagues, provide the conceptual framework for geroscience. These hallmarks include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis (Cell: from geroscience to precision geromedicine). Each hallmark represents a specific type of cellular damage or dysfunction that accumulates with age.

Geroscience operates on the premise that these hallmarks are not independent. They interact and amplify one another:

• Mitochondrial dysfunction generates reactive oxygen species that damage DNA, contributing to genomic instability.
• Genomic instability triggers cellular senescence, which drives chronic inflammation through the secretion of pro-inflammatory cytokines.
• Chronic inflammation accelerates stem cell exhaustion and impairs tissue regeneration.
• Targeting one hallmark can have downstream effects on others due to this interconnected network.

The hallmarks also explain why aging increases susceptibility to such a wide range of diseases. Cardiovascular disease is driven by endothelial dysfunction, vascular inflammation, and impaired repair mechanisms, all downstream consequences of mitochondrial dysfunction, cellular senescence, and chronic inflammation. Cancer risk increases with genomic instability and loss of proteostasis, which allow damaged cells to evade normal regulatory checkpoints. Neurodegeneration reflects the accumulation of misfolded proteins, mitochondrial failure, and impaired autophagy. By addressing the hallmarks, geroscience aims to reduce risk across multiple disease categories simultaneously.

What Drives the Aging Process and What Slows It Down

The rate at which the hallmarks of aging accumulate is not fixed. It's influenced by diet, exercise, sleep, stress, environmental exposures, and pharmacological interventions. Understanding these inputs is central to translating geroscience into practice.

Metabolic signaling and nutrient sensing

Caloric restriction and intermittent fasting activate pathways that promote cellular repair and stress resistance. These interventions reduce mTOR signaling, a nutrient-sensing pathway that promotes growth but also accelerates aging when chronically activated. Conversely, chronic overnutrition and high glycemic load drive insulin resistance, advanced glycation end-product accumulation, and mitochondrial dysfunction.

Exercise and mitochondrial biogenesis

Aerobic exercise stimulates the production of new mitochondria through activation of PGC-1alpha, a master regulator of mitochondrial biogenesis. Resistance training activates mTOR in a pulsatile, beneficial way that supports muscle protein synthesis without the chronic activation seen in metabolic dysfunction. High-intensity interval training induces autophagy, the cellular process that clears damaged organelles and proteins.

Sleep and cellular clearance

Deep sleep is when growth hormone is secreted and the glymphatic system clears neurotoxic waste from the brain. Sleep deprivation accelerates epigenetic aging and impairs immune function. Circadian rhythm disruption, common in shift workers, is associated with metabolic dysregulation and increased cancer risk.

Chronic stress and hormonal aging

Prolonged activation of the hypothalamic-pituitary-adrenal axis elevates cortisol, which has catabolic effects on muscle and bone, suppresses immune function, and accelerates telomere shortening. Stress-induced inflammation contributes to inflammaging, the chronic low-grade inflammation that characterizes biological aging.

Environmental exposures

UV radiation causes DNA damage and accelerates skin aging. Air pollution generates systemic oxidative stress and is linked to cardiovascular and neurodegenerative disease. Heavy metals impair mitochondrial function. Endocrine-disrupting chemicals interfere with hormonal signaling and may accelerate reproductive aging.

Why the Same Aging Process Produces Different Outcomes in Different People

Two people of the same chronological age can have vastly different biological ages. One may be metabolically healthy, cognitively sharp, and physically resilient. The other may have multiple chronic diseases, cognitive decline, and frailty. Geroscience explains this divergence through individual variation in the rate at which aging hallmarks accumulate.

Genetics play a role. Variants in genes like FOXO3 and APOE influence longevity and disease risk:

• FOXO3 variants are associated with exceptional longevity and enhanced stress resistance.
• APOE4 increases risk for Alzheimer's disease and cardiovascular disease.
• Genetic determinants of telomere length and DNA repair capacity contribute to individual differences in aging rate.

Epigenetic aging, measured by DNA methylation clocks like GrimAge and DunedinPACE, captures the cumulative effect of lifestyle and environmental exposures on biological age. These clocks predict mortality and disease risk more accurately than chronological age. Importantly, they show that biological age is modifiable. Interventions that improve metabolic health, reduce inflammation, and enhance cellular repair can slow or even reverse epigenetic aging.

Metabolic phenotype matters. Individuals with high insulin sensitivity, efficient mitochondrial function, and favorable substrate utilization age more slowly than those with insulin resistance and metabolic dysfunction. Gut microbiome composition also influences aging rate. Centenarians have distinct microbiome profiles characterized by higher diversity and greater abundance of species that produce anti-inflammatory metabolites.

Hormonal milieu shapes aging trajectories. Sex hormones, growth hormone, IGF-1, and cortisol all modulate aging rate and resilience. Hormonal transitions like menopause and andropause accelerate specific aging pathways, including bone loss, muscle atrophy, and vascular dysfunction. Prior exposures (including early life adversity, cumulative stress burden, and environmental toxin exposure) contribute to allostatic load, the wear and tear on the body from chronic stress.

What the Research Actually Supports and Where the Evidence Gets Thinner

Geroscience is grounded in robust mechanistic data from model organisms. Caloric restriction extends lifespan in yeast, worms, flies, and mice. Genetic manipulations that reduce insulin/IGF-1 signaling or enhance stress resistance produce similar effects. Rapamycin, an mTOR inhibitor, extends lifespan in mice and delays age-related diseases. Metformin, a drug that activates AMPK and improves insulin sensitivity, shows promise in observational studies and is being tested in the TAME (Targeting Aging with Metformin) trial, which aims to determine whether it delays the onset of age-related diseases in humans.

Senolytics, drugs that selectively eliminate senescent cells, have shown efficacy in animal models:

• Dasatinib and quercetin, a senolytic combination, reduce senescent cell burden and improve physical function in mice.
• Early-stage human trials in disease populations show some benefit, but large-scale trials in healthy aging populations are still needed.
• NAD+ precursors like NMN and NR increase NAD+ levels, which decline with age and are required for sirtuin activity and mitochondrial function.
• Animal data are strong, but human evidence for longevity outcomes remains limited.

Epigenetic clocks are powerful tools for measuring biological age, and they correlate strongly with disease risk and mortality. However, whether interventions that move clock scores actually extend lifespan is unproven. The clocks measure association, not causation. Similarly, telomere length is a noisy biomarker with high individual variability. Longer telomeres are generally associated with better health, but the relationship is not linear, and telomere length alone is not a reliable predictor of individual aging rate.

The evidence for some interventions is genuinely strong. VO2 max, a measure of aerobic capacity, is one of the strongest predictors of all-cause mortality. Muscle mass predicts metabolic resilience and functional independence. These are not speculative biomarkers. They are validated, actionable targets. The challenge for geroscience is to identify which pharmacological interventions will prove as robust in humans as they have in model organisms.

How to Measure What Actually Matters for Your Aging Trajectory

Geroscience shifts the focus from reactive disease management to proactive aging management. This requires measuring the right biomarkers and tracking them over time. A single measurement is a snapshot. A series of measurements over time is a trajectory, and directionality matters more than any single data point.

Metabolic health is foundational:

• Fasting insulin, HbA1c, fasting glucose, and triglycerides provide insight into insulin sensitivity and glycemic control.
• ApoB, which measures the number of atherogenic lipoprotein particles, is a better predictor of cardiovascular risk than LDL cholesterol alone.
• Lipoprotein(a) is a genetically influenced risk factor that standard cholesterol panels miss.

Inflammation is a core driver of aging:

• High-sensitivity C-reactive protein (hsCRP) is the most widely used marker of systemic inflammation.
• Homocysteine reflects methylation capacity and is associated with cardiovascular and cognitive risk.
• Ferritin, when elevated in the absence of iron deficiency, can indicate inflammation or oxidative stress.

Hormonal health influences aging rate:

• IGF-1 reflects growth hormone status.
• DHEA-S declines with age and is a marker of adrenal function.
• Testosterone, estradiol, and thyroid function (TSH, Free T3, Free T4) all modulate metabolic rate, body composition, and resilience.

Nutrient status matters. Vitamin D, magnesium, B12, and folate are commonly deficient and influence everything from immune function to DNA repair. Body composition, measured by DEXA, provides data on lean mass, fat mass, and visceral fat, all of which predict metabolic and physical resilience.

Measuring What Actually Matters for How You Age

If you want to know how your body is aging at a biological level, you need more than a standard annual physical. You need a comprehensive view of the metabolic, inflammatory, and hormonal markers that drive aging rate. Superpower's 100+ biomarker panel covers fasting insulin, ApoB, Lp(a), hsCRP, homocysteine, and more (the markers that standard bloodwork typically misses). Understanding how you're aging requires tracking the inputs that matter, not just waiting for disease to appear. Geroscience gives you the framework. The right biomarkers give you the data. And longitudinal tracking gives you the trajectory. That's how you move from reacting to disease to managing the aging process itself.